A. Akdaş

3.7k total citations · 1 hit paper
102 papers, 2.7k citations indexed

About

A. Akdaş is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, A. Akdaş has authored 102 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 41 papers in Surgery and 20 papers in Urology. Recurrent topics in A. Akdaş's work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (25 papers) and Bladder and Urothelial Cancer Treatments (18 papers). A. Akdaş is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (25 papers) and Bladder and Urothelial Cancer Treatments (18 papers). A. Akdaş collaborates with scholars based in Türkiye, United States and United Kingdom. A. Akdaş's co-authors include İbrahim Çevik, Ferruh Şimşěk, Levent Türkeri, Maha Hussain, Celestia S. Higano, George Wilding, Eric J. Small, Bryan Donnelly, E. David Crawford and Jorg R. Oddens and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

A. Akdaş

97 papers receiving 2.6k citations

Hit Papers

Duration of Androgen Suppression in the Treatment of Pros... 2009 2026 2014 2020 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Akdaş Türkiye 19 1.8k 507 487 339 299 102 2.7k
M. De Pauw Belgium 24 1.0k 0.6× 497 1.0× 1.2k 2.5× 156 0.5× 193 0.6× 62 2.3k
J. Edson Pontes United States 36 2.4k 1.4× 598 1.2× 1.6k 3.4× 151 0.4× 473 1.6× 124 4.0k
Bo Johan Norlén Sweden 23 1.9k 1.1× 624 1.2× 1.1k 2.2× 87 0.3× 339 1.1× 43 3.1k
Alberto Bossi France 28 1.8k 1.0× 487 1.0× 556 1.1× 196 0.6× 256 0.9× 106 2.6k
Robert R. Bahnson United States 27 1.1k 0.6× 385 0.8× 696 1.4× 120 0.4× 407 1.4× 96 2.5k
Harmar D. Brereton United States 24 1.2k 0.7× 851 1.7× 352 0.7× 114 0.3× 203 0.7× 58 2.3k
L Boccon-Gibod France 37 2.7k 1.5× 543 1.1× 938 1.9× 656 1.9× 564 1.9× 168 4.1k
Ubirajara Ferreira Brazil 22 1.8k 1.0× 345 0.7× 602 1.2× 362 1.1× 399 1.3× 132 2.6k
Bruce A. Lowe United States 25 1.7k 1.0× 569 1.1× 1.5k 3.2× 288 0.8× 500 1.7× 53 3.4k
Raymond S. Lance United States 24 1.4k 0.8× 647 1.3× 440 0.9× 83 0.2× 864 2.9× 51 2.6k

Countries citing papers authored by A. Akdaş

Since Specialization
Citations

This map shows the geographic impact of A. Akdaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Akdaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Akdaş more than expected).

Fields of papers citing papers by A. Akdaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Akdaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Akdaş. The network helps show where A. Akdaş may publish in the future.

Co-authorship network of co-authors of A. Akdaş

This figure shows the co-authorship network connecting the top 25 collaborators of A. Akdaş. A scholar is included among the top collaborators of A. Akdaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Akdaş. A. Akdaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bolla, M., Geertjan van Tienhoven, Alphonsus C. M. van den Bergh, et al.. (2009). Duration of Androgen Suppression in the Treatment of Prostate Cancer. New England Journal of Medicine. 360(24). 2516–2527. 658 indexed citations breakdown →
2.
Çevik, İbrahim, et al.. (2008). Asymptomatic retained surgical gauze towel diagnosed 32 years after nephrectomy. International Urology and Nephrology. 40(4). 885–888. 12 indexed citations
3.
Çam, Kamil, Ferruh Şimşěk, Meral Yüksel, et al.. (2004). The role of reactive oxygen species and apoptosis in the pathogenesis of varicocele in a rat model and efficiency of vitamin E treatment. International Journal of Andrology. 27(4). 228–233. 56 indexed citations
4.
Çam, Kamil, Selçuk Yücel, Levent Türkeri, & A. Akdaş. (2002). Accuracy of transrectal ultrasound guided prostate biopsy: Histopathological correlation to matched prostatectomy specimens. International Journal of Urology. 9(5). 257–260. 23 indexed citations
5.
Çam, Kamil, et al.. (2001). Transrektal Ultrasonografi EşliğindeProstat Biyopsisinin Komplikasyonları. Turkiye Klinikleri Tip Bilimleri Dergisi. 21(4). 282–284. 2 indexed citations
6.
Türkeri, Levent N., et al.. (2001). Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.. PubMed. 54(2). 191–6. 11 indexed citations
7.
Çevik, İbrahim, et al.. (1999). Effects of Single-Shot and Twin-Shot Shockwaves on Urinary Enzyme Concentrations. Journal of Endourology. 13(6). 403–408. 7 indexed citations
8.
Atuğ, Fatih, Levent Türkeri, Mustafa Özyürek, & A. Akdaş. (1998). Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder. International Urology and Nephrology. 30(4). 455–461. 20 indexed citations
9.
Türkeri, Levent N., et al.. (1997). Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancer. British Journal of Urology. 79(3). 373–377. 36 indexed citations
10.
Tarcan, Tufan, Ferruh Şimşěk, & A. Akdaş. (1996). A review of injectable materials in the endoscopic treatment of vesicoureteral reflux. DergiPark (Istanbul University). 1 indexed citations
11.
Alkan, İlter, et al.. (1996). Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: Correlation with removed prostate weight. International Urology and Nephrology. 28(4). 517–523. 10 indexed citations
12.
Tarcan, Tufan, et al.. (1996). Economics of different treatment options of benign prostatic hyperplasia in Turkey. International Urology and Nephrology. 28(4). 525–528. 2 indexed citations
13.
Hayran, Osman, et al.. (1995). Social and Medical Aspects ofUndescended Testes in Turkey. European Urology. 28(2). 161–164. 5 indexed citations
14.
Şimşěk, Ferruh, et al.. (1995). Extracorporeal shock wave lithotripsy (ESWL) for urinary tract stones using Dornier MFL 5000, performed by the technician. International Urology and Nephrology. 27(5). 511–513. 4 indexed citations
15.
Akdaş, A., et al.. (1994). Short-Term Bioeffects of Extracorporeal Shockwave Lithotripsy. Journal of Endourology. 8(3). 187–190. 8 indexed citations
16.
Şimşěk, Ferruh, et al.. (1993). Transurethral Grooving of the Prostate in the Treatment of Patients with Benign Prostatic Hyperplasia. An Alternative to Transurethral Incision. British Journal of Urology. 72(1). 84–87. 5 indexed citations
17.
Akdaş, A., Levent Türkeri, & T Akoğlu. (1990). Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status. International Urology and Nephrology. 22(6). 501–506. 1 indexed citations
18.
Akdaş, A., et al.. (1989). Urethral Caruncle in an Unusual Location Occurring inPrepubertal Girl. European Urology. 16(2). 153–154. 5 indexed citations
19.
Akdaş, A., et al.. (1988). Bladder agenesis. International Urology and Nephrology. 20(3). 261–263. 5 indexed citations
20.
Akdaş, A., et al.. (1987). Association between HLA Antigens and Bladder Tumors. European Urology. 13(3). 207–209. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026